Covaxin, Bharat Biotech's Coronavirus Vaccine, Cleared For Phase 3 Trials

PUBLISHED ON: October 22, 2020 | Duration: 0 min, 33 sec

  
loading..
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials. The Hyderabad-based vaccine maker had applied to the Drugs Controller General of India (DCGI) on October 2, seeking its permission to conduct Phase 3 trials for its COVID-19 vaccine candidate.
ALSO WATCH
The Biggest Stories Of November 23, 2020

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com